Regarding the "HPV vaccine" to prevent uterine cancer, which is self-funded when men receive it, Governor Koike stated, "We will consider supporting wards and municipalities because it can be expected to have the effects of cancer prevention and herd immunity in men," and indicated that he would consider including subsidizing the cost of vaccination for men.
The HPV vaccine to prevent uterine cancer can be administered free of charge for women in the sixth grade of elementary school to the first year of high school, but if a man is vaccinated, it costs about 6,1 yen at their own expense in most municipalities.
In response to this, Governor Koike stated at a plenary session of the Tokyo Metropolitan Assembly, "HPV vaccine can be expected to have the effect of preventing cancer in men and herd immunity by vaccinating both men and women, and the Tokyo Metropolitan Government will consider supporting wards and municipalities for male vaccination in the future, comprehensively taking into account the status of national studies and other factors," and indicated that he would consider including subsidies for the cost of vaccination for men.
On the other hand, in relation to the fact that it may take several months to take a "developmental and intelligence test" to check for the presence or absence of developmental disabilities in children, a senior official of the Tokyo Metropolitan Board of Education said, "Since the status of testing varies depending on the ward and municipality, we will share information on good practices and work to promptly receive necessary support."